Reliable information on COVID vaccine required for Aussie GPs

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

As millions of extra Pfizer vaccines arrive on our doorstep, information on the COVID-19 vaccine rollout remains cloudy.

A new Healthed survey of almost 1000 practising GPs conducted only two weeks ago suggests GPs are unlikely to be trying to convince patients under 60 to have the AstraZeneca vaccine instead of Pfizer.

Almost half of the respondents (45.3%) believed there was not enough publicly available information from reliable sources to ensure patients under 60 could make an informed choice about having the AstraZeneca vaccine.

In addition, while more than three-quarters of the doctors in the survey said that these under-60 year old patients would most likely rely on information from their GP to make the decision about whether or not to have the AZ vaccine rather than wait for the Pfizer vaccine, almost one third of GPs (31.27%) said they did not feel sufficiently informed themselves to be able to adequately help their patients in this decision.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jo-Ann See

Dr Jo-Ann See

Management of Acne in Teens

Dr Robert Hungerford

Dr Robert Hungerford

An Update on Heart Failure in General Practice

Dr Michael Selby

Dr Michael Selby

Scoliosis in Children: Preventing Surgery

A/Prof Yvonne Zissiadis

A/Prof Yvonne Zissiadis

Innovations in Breast Radiation

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

I invite you to join the upcoming Healthed webcast where I will give an update on current radiation therapy regimens and the potential side effects of this treatment. In addition, I will present the latest learnings from breast cancer research, including the increasing recognition of the value of exercise as part of effective breast cancer management.

Tuesday 5th August, 7pm AEST